Benson Hill Inc. has reached a significant milestone in its Chapter 11 bankruptcy proceedings. On May 22, 2025, the United States Bankruptcy Court for the District of Delaware approved the sale of substantially all of Benson Hill's assets. The court authorized the Asset Sale to Confluence Genetics, LLC, which includes entities affiliated with S2G Investments, LLC, and ProAgInvest, LLC. This sale was executed under a Bankruptcy Court-approved asset purchase agreement. The agreement encompasses the assumption of certain liabilities and a cash payment to cover closing costs, contractual obligations, and a $1 million wind-down amount. Additionally, the transaction involves the settlement of the $11 million debtor-in-possession credit facility. The approval marks a crucial step in Benson Hill's restructuring process, as the company continues to operate as a debtor-in-possession while pursuing a resolution to its financial challenges.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Benson Hill Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-052703), on May 27, 2025, and is solely responsible for the information contained therein.
Comments